NXTC
NextCure, Inc.
First covered
Jul 14, 2026
Biggest move
+290.37%
at report time
Float, first → latest
2.37M → 2.37M
Dilution filings, coverage windows
0
Run history — newest first
RUN 1
Jul 14, 2026 NXTC Quadruples Premarket as Avere Therapeutics Reverse Merger Lands With $320M Behind It +290.37% at report · float 2.37M FADED D2 -22.1%
Jul 14, 2026 NXTC Quadruples Premarket as Avere Therapeutics Reverse Merger Lands With $320M Behind It +290.37% at report · float 2.37M FADED D2 -22.1%